Abstract
The investigation of metal-containing drugs over several decades has set out to improve upon the toxicity and efficacy of conventional chemotherapeutic agents. Promising pre-clinical and clinical data have fostered the broadening for the search of metal compounds in cancer treatment and combination therapy. Gallium is only second to platinum in terms of anti-tumor activity. Its subsequent investigation has been ongoing for nearly three decades, primarily in the form of salts, and more recently coordinated to organic ligands as coordination complexes. From its early investigation as a diagnostic agent to its anti-tumor potential, promising clinical results have shown a renewed interest in exploring gallium in a host of malignancies, especially lymphoma and bladder cancer. However, the detailed mechanisms of action of gallium compounds are not completely defined. Further understanding the underlying mechanisms along with optimizing the structural components of gallium complexes will further improve the therapeutic index of gallium.
Keywords: Gallium, Gallium Complexes, Drug design, Drug discovery, Metal complexes, Ligands
Letters in Drug Design & Discovery
Title: The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design
Volume: 4 Issue: 5
Author(s): Michael Frezza, Claudio N. Verani, Di Chen and Q. Ping Dou
Affiliation:
Keywords: Gallium, Gallium Complexes, Drug design, Drug discovery, Metal complexes, Ligands
Abstract: The investigation of metal-containing drugs over several decades has set out to improve upon the toxicity and efficacy of conventional chemotherapeutic agents. Promising pre-clinical and clinical data have fostered the broadening for the search of metal compounds in cancer treatment and combination therapy. Gallium is only second to platinum in terms of anti-tumor activity. Its subsequent investigation has been ongoing for nearly three decades, primarily in the form of salts, and more recently coordinated to organic ligands as coordination complexes. From its early investigation as a diagnostic agent to its anti-tumor potential, promising clinical results have shown a renewed interest in exploring gallium in a host of malignancies, especially lymphoma and bladder cancer. However, the detailed mechanisms of action of gallium compounds are not completely defined. Further understanding the underlying mechanisms along with optimizing the structural components of gallium complexes will further improve the therapeutic index of gallium.
Export Options
About this article
Cite this article as:
Frezza Michael, Verani N. Claudio, Chen Di and Dou Q. Ping, The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design, Letters in Drug Design & Discovery 2007; 4 (5) . https://dx.doi.org/10.2174/157018007780867799
DOI https://dx.doi.org/10.2174/157018007780867799 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transcriptional Control of the Oxidative Stress Response and Implications
of Using Plant Derived Molecules for Therapeutic Interventions
in Cancer
Current Medicinal Chemistry Aspirin: A Potential Therapeutic Approach in Pancreatic Cancer
Current Medicinal Chemistry Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Medicinal Chemistry Reviews - Online (Discontinued) Strategies for In Vivo siRNA Delivery in Cancer
Mini-Reviews in Medicinal Chemistry Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine Patent Selections
Recent Patents on Biomarkers Recent Advances in Azo Dye Degrading Enzyme Research
Current Protein & Peptide Science Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Current Cancer Therapy Reviews Angiogenesis Imaging Using 68Ga-RGD PET: Preliminary Report from Seoul National University Hospital
Current Medical Imaging Meet Our Editorial Board Member:
Current Medicinal Chemistry Vitamin D Metabolites and/or Analogs: Which D for Which Patient?
Current Vascular Pharmacology Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Mini-Reviews in Medicinal Chemistry Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Current Pharmaceutical Design Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents
Current Medicinal Chemistry Microtubules in Apoptosis Induction: Are They Necessary?
Current Cancer Drug Targets Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma
Current Medicinal Chemistry - Anti-Cancer Agents Editorial [Hot Topic: Hydrogen Sulfide: From Molecular Biology to Pharmacology Guest Editor: Stefano Fiorucci)]
Inflammation & Allergy - Drug Targets (Discontinued) Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets